Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRevolution Beauty Regulatory News (REVB)

Share Price Information for Revolution Beauty (REVB)

Share Price is delayed by 15 minutes
Get Live Data
4.65    0.35 (8.14%)
Bid:
4.65
Ask:
4.80
Spread: 0.15 (3.226%)
Market Cap: £40.44m
REVB Live PriceLast checked at - London Stock Exchange

Intraday Revolution Beauty Share Chart

PDMR Dealing

21 Jul 2023 13:43

RNS Number : 8439G
Revolution Beauty Group PLC
21 July 2023
 

For Immediate Release

21 July 2023

 

 

 

 

 

 

REVOLUTION BEAUTY GROUP PLC

("Revolution Beauty", the "Group" or the "Company")

 

PDMR Dealing

Revolution Beauty Group plc (AIM: REVB), the multi-channel mass beauty innovator, has been notified that Bob Holt, Interim Chief Executive Officer of the Company, sold 2,250,000 ordinary shares of £0.01 each ("Ordinary Shares") on 19 July 2023 at a price of 30p per Ordinary Share. Following this sale, Bob holds 2,376,315 Ordinary Shares of the Company.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them, provided in accordance with the requirements of the UK Market Abuse Regulation

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Robert Holt

 

2

Reason for the notification

a)

Position/status

Interim Chief Executive Officer

 

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Revolution Beauty Group plc

b)

LEI

21380083TTJWXK677H17

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.01

 

ISIN: GB00BP7L1T61

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

30p

 

Volume(s)

2,250,000

 

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

19 July 2023

f)

Place of the transaction

London Stock Exchange, AIM

 

 

 

 

For further information please contact:

Revolution Beauty Investor Relations

Elizabeth Lake

Investor.Relations@revolutionbeautyplc.com

 

Joint Corporate Brokers

 

 

Zeus (NOMAD): Nick Cowles /Jamie Peel /Jordan Warburton

 

Tel: +44 (0) 161 831 1512

Liberum: Clayton Bush / Edward Thomas / Miquela Bezuidenhoudt

 

Tel: +44 (0) 203 100 2222

Media enquiries:

Tel: +44 (0)20 3805 4822

 

Headland Consultancy

 

Mark Denham / Will Smith / Antonia Pollock

Revolutionbeauty@headlandconsultancy.com

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHNKDBQBBKDBOB
Date   Source Headline
7th Mar 20252:47 pmRNSHolding(s) in Company
28th Feb 20253:08 pmRNSTotal Voting Rights
24th Feb 20258:52 amRNSHolding(s) in Company
21st Feb 20251:50 pmRNSHolding(s) in Company
31st Jan 20257:00 amRNSTotal Voting Rights
29th Jan 20257:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
24th Jan 20252:24 pmRNSHolding(s) in Company
23rd Jan 202510:44 amRNSHolding(s) in Company
23rd Jan 20257:00 amRNSFY25 Trading Update
2nd Jan 20257:00 amRNSUpdate on claim alleged by Chrysalis Investments
2nd Jan 20257:00 amRNSTotal Voting Rights
27th Dec 202411:54 amRNSHolding(s) in Company
13th Dec 20241:05 pmRNSHolding(s) in Company
12th Dec 202410:42 amRNSHolding(s) in Company
11th Dec 20243:15 pmRNSHolding(s) in Company
2nd Dec 20243:25 pmRNSTotal Voting Rights
2nd Dec 20243:24 pmRNSHolding(s) in Company
19th Nov 20247:00 amRNSInterim Results
8th Nov 20247:00 amRNSNotice of HY25 Results
4th Nov 20247:00 amRNSNominated Adviser and Broker
4th Nov 20247:00 amRNSTotal Voting Rights
9th Oct 20247:00 amRNSHY2025 Trading Update
7th Oct 202412:40 pmRNSHolding(s) in Company
1st Oct 20247:00 amRNSTotal Voting Rights
23rd Sep 20247:00 amRNSRelated party transactions
5th Sep 20244:56 pmRNSHolding(s) in Company
30th Aug 20244:11 pmRNSHolding(s) in Company
30th Aug 20247:00 amRNSTotal Voting Rights
31st Jul 20244:59 pmRNSAnnual General Meeting
29th Jul 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
12th Jul 20247:00 amRNSNotice of Retail Investor Presentation
3rd Jul 20245:00 pmRNSNotice of AGM and posting of Annual Report
1st Jul 202412:00 pmRNSTotal Voting Rights and NOMAD name change
26th Jun 20247:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 29 FEBRUARY 2024
17th Jun 20247:00 amRNSNotice of FY24 Results
30th Apr 20244:59 pmRNSTotal Voting Rights
29th Apr 20247:00 amRNSHolding(s) in Company
22nd Apr 20249:09 amRNSResponse to allegations by Chrysalis Investments
12th Apr 20244:43 pmRNSHolding(s) in Company
4th Apr 20247:01 amRNSHolding(s) in Company
4th Apr 20247:00 amRNSHolding(s) in Company
3rd Apr 20249:40 amRNSHolding(s) in Company
27th Mar 20247:00 amRNSTrading Update
11th Mar 20241:50 pmRNSTotal Voting Rights
20th Feb 20247:00 amRNSGrant of Share Options
19th Feb 20247:00 amRNSChange of Auditor
8th Feb 20247:00 amRNSCapital Markets Event and FY24 Trading Update
5th Feb 20247:00 amRNSAdam Minto Settlement Agreement
2nd Feb 20247:00 amRNSResponse to allegations by Chrysalis Investments
26th Jan 20247:00 amRNSBlock Admission Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.